Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Bitcoin surges near $40,000 after Elon Musk says Tesla will resume crypto payments when mining is cleaner – Markets Insider
Article feature image
European markets continue march to record highs as Fed meeting looms – CNBC
Article feature image
China nuclear plant refutes report of radiation leak warning, says indicators ‘normal’ – The Washington Post